Public Policy in a Pandemic: A Hazard-Control Perspective and a Case Study of the BCG Vaccine for COVID-19
The first cases of COVID-19 were reported in China in Dec, 2019, quickly spreading to other parts of the world leading to a global pandemic. A number of potential interventions and treatments are being considered. Also in the midst of a pandemic, much early reporting can contain misleading and contradictory data. Thus, reliable information and reasoned perspectives by decision-makers must be attained to minimize the pandemic's current impact, as well as the impact in the likely second wave in the flu season of 2020-2021. One potential treatment is the use of booster doses of the BCG (Bacille Calmette-Guerin) vaccine; this vaccine is mandatory at birth in many lower-income nations. In this paper, using widely available and reliable data, the relationship of per-capita GDP (Gross Domestic Product) and the BCG vaccine's use on the impact of the virus is studied via statistical models. A strong association is seen between lower per-capita GDP and lower impact. Further, a lower impact is witnessed in countries where the BCG vaccine is mandatory at birth, which suggests that clinical trials need to occur to determine the vaccine's efficacy. Perspectives in safety and risk mitigation needed for management of pandemics and similar events are also provided.
A. Gosavi and R. J. Marley, "Public Policy in a Pandemic: A Hazard-Control Perspective and a Case Study of the BCG Vaccine for COVID-19," IEEE Engineering Management Review, Institute of Electrical and Electronics Engineers (IEEE), Jul 2020.
The definitive version is available at https://doi.org/10.1109/EMR.2020.3010438
Engineering Management and Systems Engineering
Keywords and Phrases
Pandemics; Healthcare; Strategic Management; Safety; Risk Management; BCG Vaccine; Interventions
International Standard Serial Number (ISSN)
Article - Journal
© 2020 Institute of Electrical and Electronics Engineers (IEEE), All rights reserved.
20 Jul 2020